TribLIVE

| USWorld


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Chili peppers may prove helpful in treating migraine headaches

Daily Photo Galleries

By Bloomberg News
Saturday, April 27, 2013, 9:48 p.m.
 

SAN FRANCISCO — Chili peppers and migraines have traits in common — a fact scientists are exploiting to develop drugs capable of preventing the debilitating headache's painful symptoms.

The link between how skin reacts when rubbed with chili oil and what happens in the brain during a migraine has attracted the world's largest biotechnology company, Amgen Inc., and other companies seeking to formulate medicines for the more than 36 million Americans who have migraines.

Symptoms include nausea, vomiting, dizziness and sensitivity to touch, yet treatment options are limited. Some pharmaceutical companies that have tried recently to develop migraine therapies, such as Bristol-Myers Squibb Co. and Merck & Co., have abandoned their efforts, while the few drugs on the market are ineffective for many people and carry the danger of serious side effects for those at risk of heat attack or stroke.

“Migraines are an extremely common disorder, and it affects people really in the prime of their lives,” said Rob Lenz, who is leading Amgen's migraine drug development.

Still, no drugs have been “developed specifically for the treatment of migraines,” Lenz said. “They were developed as anti-epileptics, or blood pressure-lowering agents.”

That may soon change. Amgen, based in Thousand Oaks, Calif., and other biotechnology companies such as Alder Biopharmaceuticals Inc., Arteaus Therapeutics, and Labrys Biologics Inc. are targeting a chemical released during a migraine that carries a “pain” signal from nerve to nerve. By blocking a receptor from receiving the message, these companies aim to develop drugs that cut off migraines before symptoms start.

Similar pain signal transmission occurs when chili oil touches the skin. In that situation, the capsaicin in the pepper causes the body to release calcitonin gene-related peptides, or CGRP, leading to an increase in blood flow to the affected area.

To show the Amgen drug works, researchers injected it under the skin of patients who had chili oil on their skin. The therapy blocked the CGRP that causes increased blood flow.

“It sounds simple, but it's important — it tells us that our drug is getting into the body in relative concentrations that are generally well tolerated and that block CGRP,” Lenz said.

The new class of drugs under development are biologics, often delivered by injection, and are more complex, targeted and longer-lasting in the body than the earlier failed attempts, Lenz said.

Subscribe today! Click here for our subscription offers.

 

 
 


Show commenting policy

Most-Read Nation

  1. Ramping up e-cigarette voltage may be more hazardous to health
  2. Obama to seek protection of wilderness designation for Alaska refuge
  3. Arizona hospital tests brain tumor drugs by giving patients dose, then operating
  4. New York father kils 3 generations of family, himself
  5. Snowstorm crawls up coast, hitting New York, New Jersey, Connecticut, parts of Pennsylvania
  6. Gunfire kills 3 at party in vacant house in Omaha
  7. Rosetta spacecraft providing data on its comet traveling partner
  8. Vanderbilt University gang-rape defense points to campus culture
  9. Grandma thwarts Oregon purse-snatcher who can’t shake her off car
  10. Marine Corps’ general outlines priorities, vision
  11. Boy, 13, arrested in fatal stabbing at David Wark Griffith Middle School in East Los Angeles